Cholesterol and Lipid Test Market Outlook from 2024 to 2034

The global cholesterol and lipid test market size reached US$ 2.7 billion in 2023 and is anticipated to expand at a 7.6% CAGR during the forecast period. Total market valuation is predicted to increase from US$ 3.0 billion in 2024 to US$ 6.2 billion by 2034.

Attributes Key Insights
Cholesterol and Lipid Test Market Value in 2023 US$ 2.7 billion
Estimated Cholesterol and Lipid Test Market Value (2024E) US$ 3.0 billion
Projected Cholesterol and Lipid Test Market Value (2034F) US$ 6.2 billion
Expected Cholesterol and Lipid Test Market CAGR of (2024 to 2034) 7.6%
Market Share of Top 5 Countries 51.9%

Cholesterol and Lipid Test Market Overview

Cholesterol and lipid tests are becoming ideal means of monitoring and maintaining cholesterol levels in the body. These tests are set to help detect bad cholesterol or low-density lipoprotein (LDL) and different cardiovascular diseases.

High cholesterol levels often lead to atherosclerosis, narrowing the arteries and making it more difficult for blood to flow through the vessels. This can result in the development of cardiovascular illnesses. The rising need for atherosclerosis screening for early detection and treatment is expected to fuel sales of cholesterol and lipid test solutions.

A routine blood cholesterol test should be performed to ascertain the level of cholesterol accumulation. The recommended total cholesterol level is 200mg/dL or below (ATP III), according to the National Cholesterol Education Programme (NCEP) Third Adult Treatment Panel.

The NCEP suggests that triglyceride levels be less than 150 mg/dL, HDL levels above or equal to 40 mg/dL, and LDL levels less than 100 mg/dL. For this purpose, cholesterol and lipid tests are widely used.

Other factors influencing market growth include:

  • Growing need for advanced cardiovascular health testing solutions
  • Advancements in the cholesterol testing products & services market
  • Rising interest in preventive healthcare
  • Growing popularity of point-of-care testing (POCT)

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Historical Performance Vs. Global Cholesterol and Lipid Test Market Forecast

The cholesterol and lipid test market expanded historically at a CAGR of 7.6% between 2019 and 2023. It attained a value of around US$ 2.7 billion at the end of 2023.

In 2022, the cholesterol and lipid test market accounted for around 9.6% of the global rapid test market, valued at US$ 28.5 billion. Over the forecast period, the global market for cholesterol and lipid tests is anticipated to expand at a CAGR of 7.6%.

Historical CAGR (2019 to 2023) 7.6%
Forecast CAGR (2024 to 2034) 7.6%

Cholesterol and lipid testing have been critical to cardiovascular disease management for several decades. The development of cholesterol testing began in the mid-20th century with the introduction of tests for total cholesterol levels.

The market for cholesterol and lipids tests is anticipated to expand as a result of the rising demand for over-the-counter cholesterol and lipids test kits and expanding electronic miniaturization. Subsequently, the rising popularity of preventive healthcare, the development of self-testing kits, and raising awareness about the importance of cholesterol level assessment will boost the market.

The aging population and the widespread adoption of the Western lifestyle in developing nations result in higher levels of atherogenic dyslipidemia and cholesterol. This is expected to fuel sales of cholesterol and lipid test products.

Cardiovascular diseases, including heart disease and strokes, remain a leading cause of mortality worldwide. The rising prevalence of these conditions and the growing awareness of the importance of cholesterol and lipid management are expected to drive the demand for cholesterol and lipids tests.

There is also a shift toward proactive healthcare and preventive measures to mitigate the risk of cardiovascular diseases. Cholesterol and lipid tests are crucial for identifying individuals at risk and guiding preventive strategies. The emphasis on preventive care is expected to fuel cholesterol and lipid test industry demand.

Opportunities for Key Manufacturers of Cholesterol and Lipid Test Products

Demand for early diagnosis and treatment is anticipated to increase rapidly. This is due to the increasing prevalence of cardiovascular illnesses and their risk factors, including diabetes and hypertension.

Regular cholesterol and lipids testing is necessary for patients with a history of heart attacks to assess how well their therapy is working. As a result, the cholesterol and lipid test market is anticipated to expand steadily throughout the forecast period due to the increasing incidence of cardiac illnesses.

There is a growing emphasis on preventive healthcare to address the burden of cardiovascular diseases. Cholesterol and lipids tests are essential for early detection, risk assessment, and monitoring of lipid profiles. The increasing adoption of preventive healthcare strategies opens up opportunities for the market.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Challenges Limiting Expansion of Cholesterol and Lipid Test Market

Long-term difficulties with cost, misinterpretation of the electronic result, and fasting before cholesterol testing could significantly limit the use of cholesterol and lipid tests during the forecast period. Similarly, the lack of LDL and HDL testing characteristics will restrain market growth.

Understanding the results of a handful of at-home cholesterol test kits can be challenging since they are tough to use. End-users might not get an accurate result if the tool is not used properly. It could be more expensive to get electronic testing kits or cholesterol test kits that check triglycerides, LDL, and HDL levels.

Certain cholesterol and lipid tests require end-users to send a blood sample to the laboratory for analysis. This can cost money and put users through weeks of waiting for results.

Comparative View of Adjacent Cholesterol and Lipid Test Markets

The global market for cholesterol and lipid tests is set to be impacted by the peer or tangential markets in the healthcare industry. This includes the global cholesterol monitor market and the cholesterol API market. On analysis of these related industries, profound insights have been found that will be helpful for developing unique differentiating strategies to pursue growth and opportunity.

Cholesterol and Lipid Test Market:

Attribute Global Cholesterol and Lipid Test Industry
CAGR (2024 to 2034) 7.6%
Growth Factor The rising prevalence of cardiovascular diseases is a key factor driving the growth of the cholesterol and monitor test market.
Key Trend The growing popularity of point-of-care cholesterol testing and rising interest in preventive healthcare are key cholesterol and lipid test market trends.

Cholesterol Monitor Market:

Attribute Cholesterol Monitor Industry
CAGR (2024 to 2034) 7.3%
Growth Factor The increasing geriatric population and rising obesity rates are set to boost the growth of the global cholesterol monitor market.
Key Trend Rising emphasis on early diagnosis and miniaturization of cholesterol monitors are key trends in the market shaping growth.

Cholesterol Active Pharmaceutical Ingredient (API) Market:

Attribute Cholesterol API Industry
CAGR (2024 to 2034) 4.7%
Growth Factor The increasing incidence of cardiovascular diseases is predicted to expand the global active pharmaceutical ingredient (API) market size through 2034.
Key Trend The rise in outsourcing of manufacturing operations is a key trend in the global cholesterol API market.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country Wise Insights

The table below shows the anticipated growth rates of the top countries. India, Germany, and the United Kingdom are expected to record lucrative CAGRs of 8.4%, 7.6%, and 7.8%, respectively, through 2034.

Countries CAGR (2024 to 2034)
United States 6.4%
China 6.8%
United Kingdom 7.8%
Japan 6.5%
Germany 7.6%
India 8.4%

Rising Prevalence of Obesity Boosting the United States Market

The United States held a significant revenue share of about 90.6% of the North America cholesterol and lipid test market in 2023. The total cholesterol and lipid test market value in the United States reached US$ 787.02 million at the end of 2023.

As per the latest report, demand for cholesterol and lipid tests in the United States is projected to rise at a 6.4% CAGR through 2034. This is attributable to the rising rates of obesity and heart disease in the United States and the increasing need for preventive healthcare.

There has been a sharp rise in the cases of obesity and other cardiovascular diseases in the United States during the last several years. For instance, as per the 2017 to 2018 National Health and Nutrition Examination Survey (NHANES), around 42% of the United States-based adults aged 20 and over had obesity.

Obesity and other cardiovascular diseases are often linked to high cholesterol levels. As a result, demand for cholesterol and lipid tests is expected to rise rapidly in the country. This is because these tests can help in the early detection and monitoring of CVD risk by providing accurate cholesterol level assessment.

The United States government and several organizations are increasing their efforts to raise public awareness about cardiovascular diseases, including their diagnosis and treatments. This will likely improve the United States cholesterol and lipid test market share through 2034.

Increasing Government Initiatives to Fuel Demand in Germany

Germany’s cholesterol and lipid test market value totaled US$ 157.10 million in 2023. Over the forecast period, demand for cholesterol and lipid test products in Germany is predicted to rise at a 7.6% CAGR.

Multiple factors are expected to drive cholesterol and lipid test demand in Germany. These include increasing cases of cardiovascular diseases, rising need for lipoprotein measurement to detect the risk of cardiovascular diseases, and rising support from the government and other organizations.

The National Nutrition Society is a key player in Germany's effort to create clinical standards for treating cardiovascular disease. It has created new health promotion initiatives, especially in light of the nation’s growth in diabetes and obesity.

The new promotional strategies and policies will likely boost the adoption rate of cholesterol and lipid testing devices in the country. This will foster the growth of the cholesterol and lipid test market in Germany.

Advancements in Testing Technologies Fostering Growth in China

China dominated the East Asia cholesterol and lipid test market in 2023 with a share of about 45.3%. Total cholesterol and lipid test revenue in China reached US$ 194.01 million at the end of 2023.

Over the forecast period, China’s cholesterol and lipid test industry size is projected to expand at a 6.8% CAGR. This is attributable to rising obesity rates across the country, advancements in cholesterol testing technologies, and the portability of electronics and their usefulness in the creation of self-testing kits.

Thanks to advancements in testing technologies, China-based companies are developing more convenient and accurate cholesterol and lipid testing methods. These include home testing kits, pint-of-care testing devices, and other advanced laboratory-based tests. This is expected to improve China's cholesterol and lipid test market share.

Rising Interest in Cholesterol Management to Boost the United Kingdom

The United Kingdom’s cholesterol and lipid test market size reached US$ 137.09 million in 2023. For the projection period, a CAGR of 7.8% has been predicted for the United Kingdom’s cholesterol and lipid test industry.

Several factors are expected to boost the growth of the cholesterol and lipid test market in the United Kingdom. These include rising incidence of cholesterol and lipid disorder and rising awareness about the benefits of cholesterol & lipid management.

People across the United Kingdom are becoming aware of the importance of cholesterol and lipid management for preventing cardiovascular disorders. As a result, they are opting for different cholesterol and lipid tests, thereby fostering market growth.

Increasing Incidence of Cardiovascular Diseases Propelling Demand in India

India is emerging as a highly lucrative market for cholesterol and lipid testing products across South Asia. This is due to the rising incidence of cardiovascular disease, increasing government initiatives, and expanding healthcare infrastructure.

The cholesterol and lipid test market value in India totaled US$ 79.74 million in 2023. Over the forecast period, demand for cholesterol and lipid tests in India is anticipated to rise at an 8.4% CAGR.

Growing demand for liquid profile diagnostics is another key factor expected to fuel sales of cholesterol and lipid test products. Subsequently, increasing emphasis on blood lipid analysis to determine the risk of developing cardiovascular disease will foster growth.

Category-wise Insights

The section below shows the analyzer kits leading the cholesterol and lipid test market. It is poised to exhibit a CAGR of 7.4% during the forecast period. By test type, the total cholesterol test asthma segment is anticipated to thrive at 6.0% CAGR.

Based on application, the hyperlipidemia segment is expected to dominate the global cholesterol and lipid test industry. It will likely expand at 6.9% CAGR between 2024 and 2034. By end-user, the hospital segment is projected to register a CAGR of 7.5% through 2034.

Demand Remains High for Analyzer Kits Worldwide

Market Growth Outlook by Product

Product Value CAGR
Test Strip Kits 8.3%
Analyzer Kits 7.4%

Based on product, the analyzer kits segment generated a revenue of US$ 1.9 billion in 2023. Over the assessment period, demand for analyzer kits is projected to rise at a CAGR of 7.4%. This is due to the rising usage of analyzer kits in a variety of settings, including hospitals, clinics, and diagnostic centers.

Advancements in analyzer kits will also drive growth of the target segment. Patients now have better access to cholesterol testing due to the development of cutting-edge testing kits.

High Prevalence of Cardiovascular Diseases Fueling Total Cholesterol Test Demand

Market Growth Outlook by Test Type

Test Type Value CAGR
Total Cholesterol Test 6.0%
HDL Cholesterol Test 7.1%
LDL Cholesterol Test 7.9%
Triglycerides/VLDL Cholesterol Test 8.7%
Others 9.0%

By test type, the total cholesterol test segment attained a valuation of US$ 704.0 million in 2023. Over the forecast period, the target segment is anticipated to thrive at a healthy CAGR of 6.0%. It will likely retain its dominance throughout the assessment period.

Demand for total cholesterol tests is anticipated to increase due to the rising prevalence of cardiovascular illnesses and related risk factors, including diabetes and hypertension. Similarly, increasing the prevalence of high cholesterol and other related diseases will also boost the target segment.

Regular cholesterol testing is necessary for patients with a history of heart attacks to assess the efficacy of their medication. As a result, demand for total cholesterol tests is anticipated to rise significantly throughout the forecast period due to the rising prevalence of cardiac disorders.

Hyperlipidemia Remains a Key Revenue-generation Application

Market Growth Outlook by Application

Application Value CAGR
Hyperlipidemia 6.9%
Hypertriglyceridemia 8.0%
Hyperlipoproteinemia 8.5%
Tangier Disease 6.4%
Familial Hypercholesterolemia 7.5%
Others 8.8%

Based on application, the hyperlipidemia segment dominated the global cholesterol and lipid test market, holding a value share of about 25.9% in 2023. It will likely expand at a 6.9% CAGR through 2034. This is attributable to the rising prevalence of hyperlipidemia globally.

Poor dietary habits, characterized by high intake of saturated fats, trans fats, and cholesterol-rich foods, contribute to the development of hyperlipidemia. The rising incidence of this medical condition is expected to create demand for cholesterol and lipid tests.

Consuming foods such as red meat, full-fat dairy products, fried foods, and processed snacks can elevate cholesterol levels, especially low-density lipoprotein (LDL) cholesterol, commonly referred to as "bad" cholesterol. This will foster the growth of the target segment.

Hospitals Remain the Leading End-users of Cholesterol and Lipid Test Products

Market Growth Outlook by End-user

End-user Value CAGR
Clinics 6.8%
Hospitals 7.5%
Ambulatory Surgical Centers 8.3%
Homecare Settings 7.8%
Diagnostic Centers 7.2%

By end-users, the adoption of cholesterol and lipid test products remains high in hospitals. The target segment generated a revenue of about US$ 765.5 million in 2023, holding 28.1% of the total market share.

For the assessment period, the hospitals segment is poised to exhibit a CAGR of 7.5%. This is due to the rising preference of people towards opting for cholesterol and lipid tests in hospitals due to lower costs.

Patients’ preference over choosing hospitals also includes factors such as disease severity, medical personnel availability, and availability of advanced machinery & better healthcare facilities. Hence, the hospital segment will continue to dominate the target market through 2034.

Competitive Landscape

In recent years, leading players have introduced new technologies and products in the cholesterol and lipid test market. For example, Boditech Med introduced Ichorma LDL Cholesterol Direct in October 2021, and Ichroma AST secured export licenses. Both serve as warning signs for preventing lifestyle disorders, including arteriosclerosis, hypertension, diabetes, stroke, liver disease, etc.

Recent Developments in the Cholesterol and Lipid Test Market

  • In January 2022, CallonDoc released its at-home testing kits. By using these kits, users can check themselves for several ailments, including thyroid issues, STDs, diabetes, liver, kidney, and cholesterol issues.
  • In August 2019, the ‘CURO L7’ product was introduced by SD BIO. It is a home lipid cholesterol test kit that is FDA-approved and has features like an immediate blood profile in three minutes with several biomarker tests.

Cholesterol and Lipid Test Market Segments

By Product:

  • Test Strip Kits
  • Analyzer Kits

By Test Type:

  • Total Cholesterol Test
  • HDL Cholesterol Test
  • LDL Cholesterol Test
  • Triglycerides/VLDL Cholesterol Test
  • Others

By Application:

  • Hyperlipidemia
  • Hypertriglyceridemia
  • Hyperlipoproteinemia
  • Tangier Disease
  • Familial Hypercholesterolemia
  • Others

By End-user:

  • Clinics
  • Hospitals
  • Ambulatory Surgical Centers
  • Homecare Settings
  • Diagnostic Centers

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Frequently Asked Questions

How big is the cholesterol and lipid test market?

The global cholesterol and lipid test market value totaled US$ 2.7 billion in 2023.

What is the demand outlook for cholesterol and lipid tests?

Demand for cholesterol and lipid tests is expected to expand at a 7.6% CAGR.

What is the expected cholesterol and lipid test market size in 2034?

By 2034, the market size is set to reach US$ 6.2 billion.

Who are the top players in the cholesterol and lipid test market?

Abbott Laboratories, AstraZeneca, LivaNova, and Boston Scientific Corporation.

Which are the top 5 countries driving demand for cholesterol and lipid tests?

Germany, the United States, China, Japan, and the United Kingdom.

How big is the North America cholesterol and lipid test market?

North America held a market share of 31.9% in 2023.

What are the key factors driving the cholesterol and lipid test industry?

Technology advancement in tests and rising prevalence of obesity.

What is the demand outlook for Europe's cholesterol and lipid test market?

Demand in Europe is expected to rise at 8.4% CAGR through 2034.

How much does a lipid cholesterol test cost?

It costs around 320 to 250 rupees in India.

What is the test for cholesterol for lipids?

A blood test is used to measure levels of cholesterol and other fats in blood.

What is the cost of a cholesterol lipid profile?

Cholesterol lipid profile test price varies from 340 to 1000 in India.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Market Round Offs

    1.5. Future Market Insights (FMI) Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Trends & Dynamics 

    3.1. Per capita spending on cholesterol and Lipids tests

    3.2. Key Trends Impacting the Market

    3.3. Product Innovation / Development Trends

        3.3.1. Latest Trends and Demands

        3.3.2. Latest Innovations and New Launches

    3.4. Future Prospects of Industry

    3.5. Market Dynamics

        3.5.1. Drivers

        3.5.2. Restraints

        3.5.3. Opportunity Analysis

4. Value-Added Insights

    4.1. Product Adoption / Usage Analysis

    4.2. New Product Launches

    4.3. Regulatory Landscape, By Country

    4.4. PESTEL Analysis

    4.5. Porter’s Five Force Analysis

    4.6. Value Chain Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Expenditure

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Key Player’s Historic Growth

        5.2.2. Market Consolidation Activities

        5.2.3. Increasing Prevalence of Cardiovascular Diseases

        5.2.4. Government Initiatives for Early Detection

        5.2.5. Technological Advancements in Testing Methods

        5.2.6. Growing Focus on Preventive Healthcare

        5.2.7. Cost of the Tests

6. Global Market Demand Volume (Units) Analysis 2019 to 2023 and Forecast, 2024 to 2034

    6.1. Historical Market Volume (Units) Analysis, 2019 to 2023

    6.2. Current and Future Market Volume (Units) Projections, 2024 to 2034

        6.2.1. Y-o-Y Growth Trend Analysis *Per Capita Consumption

7. Global Market - Pricing Analysis

    7.1. Regional Pricing Analysis By Product

    7.2. Global Average Pricing Analysis Benchmark

    7.3. Pricing Assumptions

8. Global Market Demand (in Value or Size in US$ billion) Analysis 2019 to 2023 and Forecast, 2024 to 2034

    8.1. Historical Market Value (US$ billion) Analysis, 2019 to 2023

    8.2. Current and Future Market Value (US$ billion) Projections, 2024 to 2034

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

    8.3. Revenue Opportunity Scenario- Likely/Conservative/Optimistic

9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Product

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ billion) and Volume (Units) By Product, 2019 to 2023

    9.3. Current and Future Market Size (US$ billion) and Volume (Units) Analysis and Forecast By Product, 2024 to 2034

        9.3.1. Test Strip Kits

        9.3.2. Analyzer Kits

    9.4. Market Attractiveness Analysis By Product

10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Test Type

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ billion) Analysis By Test Type, 2019 to 2023

    10.3. Current and Future Market Size (US$ billion) Analysis and Forecast By Test Type, 2024 to 2034

        10.3.1. Total Cholesterol Test

        10.3.2. HDL Cholesterol Test

        10.3.3. LDL Cholesterol Test

        10.3.4. Triglycerides/VLDL Cholesterol Test

        10.3.5. Other

    10.4. Market Attractiveness Analysis By Test Type

11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Application

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ billion) Analysis By Application, 2019 to 2023

    11.3. Current and Future Market Size (US$ billion) Analysis and Forecast By Application, 2024 to 2034

        11.3.1. HyperLipidemia

        11.3.2. Hypertriglyceridemia

        11.3.3. Hyperlipoproteinemia

        11.3.4. Tangier Disease

        11.3.5. Familial Hypercholesterolemia

        11.3.6. Others

    11.4. Market Attractiveness Analysis By Application

12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by End User

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ billion) Analysis, By End User, 2019 to 2023

    12.3. Current and Future Market Size (US$ billion) Analysis and Forecast By End User, 2024 to 2034

        12.3.1. Clinics

        12.3.2. Hospitals

        12.3.3. Ambulatory Surgical Centers

        12.3.4. Homecare Settings

        12.3.5. Diagnostic Centers

    12.4. Market Attractiveness Analysis By End User

13. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ billion) and Volume (Units) Analysis, By Region, 2019 to 2023

    13.3. Current and Future Market Size (US$ billion) and Volume (Units) Analysis and Forecast By Region, 2024 to 2034

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. South Asia

        13.3.5. East Asia

        13.3.6. Oceania

        13.3.7. Middle East & Africa

    13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    14.1. Introduction

    14.2. Historical Market Size (US$ billion) and Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    14.3. Current and Future Market Size (US$ billion) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024 to 2034

        14.3.1. By Country

            14.3.1.1. United States

            14.3.1.2. Canada

        14.3.2. By Product

        14.3.3. By Test Type

        14.3.4. By Application

        14.3.5. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Product

        14.4.3. By Test Type

        14.4.4. By Application

        14.4.5. By End User

    14.5. Market Trends

    14.6. Market Drivers & Restraints – Intensity Mapping

    14.7. Country-Level Analysis & Forecast

        14.7.1. United States Market

            14.7.1.1. Introduction

            14.7.1.2. Market Analysis and Forecast by Market Taxonomy

                14.7.1.2.1. By Product

                14.7.1.2.2. By Test Type

                14.7.1.2.3. By Application

                14.7.1.2.4. By End User

        14.7.2. Canada Market

            14.7.2.1. Introduction

            14.7.2.2. Market Analysis and Forecast by Market Taxonomy

                14.7.2.2.1. By Product

                14.7.2.2.2. By Test Type

                14.7.2.2.3. By Application

                14.7.2.2.4. By End User

15. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    15.1. Introduction

    15.2. Historical Market Size (US$ billion) and Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    15.3. Current and Future Market Size (US$ billion) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024 to 2034

        15.3.1. By Country

            15.3.1.1. Brazil

            15.3.1.2. Mexico

            15.3.1.3. Argentina

            15.3.1.4. Rest of LATAM

        15.3.2. By Product

        15.3.3. By Test Type

        15.3.4. By Application

        15.3.5. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Product

        15.4.3. By Test Type

        15.4.4. By Application

        15.4.5. By End User

    15.5. Market Trends

    15.6. Market Drivers & Restraints – Intensity Mapping

    15.7. Country Level Analysis & Forecast

        15.7.1. Brazil Market

            15.7.1.1. Introduction

            15.7.1.2. Market Analysis and Forecast by Market Taxonomy

                15.7.1.2.1. By Product

                15.7.1.2.2. By Test Type

                15.7.1.2.3. By Application

                15.7.1.2.4. By End User

        15.7.2. Mexico Market

            15.7.2.1. Introduction

            15.7.2.2. Market Analysis and Forecast by Market Taxonomy

                15.7.2.2.1. By Product

                15.7.2.2.2. By Test Type

                15.7.2.2.3. By Application

                15.7.2.2.4. By End User

        15.7.3. Argentina Market

            15.7.3.1. Introduction

            15.7.3.2. Market Analysis and Forecast by Market Taxonomy

                15.7.3.2.1. By Product

                15.7.3.2.2. By Test Type

                15.7.3.2.3. By Application

                15.7.3.2.4. By End User

16. Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    16.1. Introduction

    16.2. Historical Market Size (US$ billion) and Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    16.3. Current and Future Market Size (US$ billion) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024 to 2034

        16.3.1. By Country

            16.3.1.1. United Kingdom

            16.3.1.2. Germany

            16.3.1.3. Italy

            16.3.1.4. France

            16.3.1.5. Spain

            16.3.1.6. Russia

            16.3.1.7. BENELUX

            16.3.1.8. Rest of Europe

        16.3.2. By Product

        16.3.3. By Test Type

        16.3.4. By Application

        16.3.5. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Product

        16.4.3. By Test Type

        16.4.4. By Application

        16.4.5. By End User

    16.5. Market Trends

    16.6. Market Drivers & Restraints – Intensity Mapping

    16.7. Country Level Analysis & Forecast

        16.7.1. United Kingdom Market

            16.7.1.1. Introduction

            16.7.1.2. Market Analysis and Forecast by Market Taxonomy

                16.7.1.2.1. By Product

                16.7.1.2.2. By Test Type

                16.7.1.2.3. By Application

                16.7.1.2.4. By End User

        16.7.2. Germany Market

            16.7.2.1. Introduction

            16.7.2.2. Market Analysis and Forecast by Market Taxonomy

                16.7.2.2.1. By Product

                16.7.2.2.2. By Test Type

                16.7.2.2.3. By Application

                16.7.2.2.4. By End User

        16.7.3. Italy Market

            16.7.3.1. Introduction

            16.7.3.2. Market Analysis and Forecast by Market Taxonomy

                16.7.3.2.1. By Product

                16.7.3.2.2. By Test Type

                16.7.3.2.3. By Application

                16.7.3.2.4. By End User

        16.7.4. France Market

            16.7.4.1. Introduction

            16.7.4.2. Market Analysis and Forecast by Market Taxonomy

                16.7.4.2.1. By Product

                16.7.4.2.2. By Test Type

                16.7.4.2.3. By Application

                16.7.4.2.4. By End User

        16.7.5. Spain Market

            16.7.5.1. Introduction

            16.7.5.2. Market Analysis and Forecast by Market Taxonomy

                16.7.5.2.1. By Product

                16.7.5.2.2. By Test Type

                16.7.5.2.3. By Application

                16.7.5.2.4. By End User

        16.7.6. Russia Market

            16.7.6.1. Introduction

            16.7.6.2. Market Analysis and Forecast by Market Taxonomy

                16.7.6.2.1. By Product

                16.7.6.2.2. By Test Type

                16.7.6.2.3. By Application

                16.7.6.2.4. By End User

        16.7.7. BENELUX Market

            16.7.7.1. Introduction

            16.7.7.2. Market Analysis and Forecast by Market Taxonomy

                16.7.7.2.1. By Product

                16.7.7.2.2. By Test Type

                16.7.7.2.3. By Application

                16.7.7.2.4. By End User

17. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    17.1. Introduction

    17.2. Historical Market Size (US$ billion) and Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    17.3. Current and Future Market Size (US$ billion) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024 to 2034

        17.3.1. By Country

            17.3.1.1. China

            17.3.1.2. Japan

            17.3.1.3. South Korea

        17.3.2. By Test Type

        17.3.3. By Application

        17.3.4. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Product

        17.4.3. By Test Type

        17.4.4. By Application

        17.4.5. By End User

    17.5. Market Trends

    17.6. Market Drivers & Restraints – Intensity Mapping

    17.7. Country Level Analysis & Forecast

        17.7.1. China Market

            17.7.1.1. Introduction

            17.7.1.2. Market Analysis and Forecast by Market Taxonomy

                17.7.1.2.1. By Product

                17.7.1.2.2. By Test Type

                17.7.1.2.3. By Application

                17.7.1.2.4. By End User

        17.7.2. Japan Market

            17.7.2.1. Introduction

            17.7.2.2. Market Analysis and Forecast by Market Taxonomy

                17.7.2.2.1. By Product

                17.7.2.2.2. By Test Type

                17.7.2.2.3. By Application

                17.7.2.2.4. By End User

        17.7.3. South Korea Market

            17.7.3.1. Introduction

            17.7.3.2. Market Analysis and Forecast by Market Taxonomy

                17.7.3.2.1. By Product

                17.7.3.2.2. By Test Type

                17.7.3.2.3. By Application

                17.7.3.2.4. By End User

18. South Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    18.1. Introduction

    18.2. Historical Market Size (US$ billion) and Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    18.3. Current and Future Market Size (US$ billion) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024 to 2034

        18.3.1. By Country

            18.3.1.1. India

            18.3.1.2. Indonesia

            18.3.1.3. Thailand

            18.3.1.4. Malaysia

            18.3.1.5. Rest of South Asia

        18.3.2. By Product

        18.3.3. By Test Type

        18.3.4. By Application

        18.3.5. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Product

        18.4.3. By Test Type

        18.4.4. By Application

        18.4.5. By End User

    18.5. Market Trends

    18.6. Market Drivers & Restraints – Intensity Mapping

    18.7. Country Level Analysis & Forecast

        18.7.1. India Market

            18.7.1.1. Introduction

            18.7.1.2. Market Analysis and Forecast by Market Taxonomy

                18.7.1.2.1. By Product

                18.7.1.2.2. By Test Type

                18.7.1.2.3. By Application

                18.7.1.2.4. By End User

        18.7.2. Indonesia Market

            18.7.2.1. Introduction

            18.7.2.2. Market Analysis and Forecast by Market Taxonomy

                18.7.2.2.1. By Product

                18.7.2.2.2. By Test Type

                18.7.2.2.3. By Application

                18.7.2.2.4. By End User

        18.7.3. Thailand Market

            18.7.3.1. Introduction

            18.7.3.2. Market Analysis and Forecast by Market Taxonomy

                18.7.3.2.1. By Product

                18.7.3.2.2. By Test Type

                18.7.3.2.3. By Application

                18.7.3.2.4. By End User

        18.7.4. Malaysia Market

            18.7.4.1. Introduction

            18.7.4.2. Market Analysis and Forecast by Market Taxonomy

                18.7.4.2.1. By Product

                18.7.4.2.2. By Test Type

                18.7.4.2.3. By Application

                18.7.4.2.4. By End User

19. Oceania Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    19.1. Introduction

    19.2. Historical Market Size (US$ billion) and Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    19.3. Current and Future Market Size (US$ billion) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024 to 2034

        19.3.1. By Country

            19.3.1.1. Australia

            19.3.1.2. New Zealand

        19.3.2. By Product

        19.3.3. By Test Type

        19.3.4. By Application

        19.3.5. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Product

        19.4.3. By Test Type

        19.4.4. By Application

        19.4.5. By End User

    19.5. Market Trends

    19.6. Market Drivers & Restraints – Intensity Mapping

    19.7. Country Level Analysis & Forecast

        19.7.1. Australia Market

            19.7.1.1. Introduction

            19.7.1.2. Market Analysis and Forecast by Market Taxonomy

                19.7.1.2.1. By Product

                19.7.1.2.2. By Test Type

                19.7.1.2.3. By Application

                19.7.1.2.4. By End User

        19.7.2. New Zealand Market

            19.7.2.1. Introduction

            19.7.2.2. Market Analysis and Forecast by Market Taxonomy

                19.7.2.2.1. By Product

                19.7.2.2.2. By Test Type

                19.7.2.2.3. By Application

                19.7.2.2.4. By End User

20. Middle East & Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    20.1. Introduction

    20.2. Historical Market Size (US$ billion) and Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    20.3. Current and Future Market Size (US$ billion) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024 to 2034

        20.3.1. By Country

            20.3.1.1. GCC Countries

            20.3.1.2. Türkiye

            20.3.1.3. South Africa

            20.3.1.4. North Africa

            20.3.1.5. Rest of Middle East & Africa

        20.3.2. By Product

        20.3.3. By Test Type

        20.3.4. By Application

        20.3.5. By End User

    20.4. Market Attractiveness Analysis

        20.4.1. By Country

        20.4.2. By Product

        20.4.3. By Test Type

        20.4.4. By Application

        20.4.5. By End User

    20.5. Market Trends

    20.6. Market Drivers & Restraints – Intensity Mapping

    20.7. Country Level Analysis & Forecast

        20.7.1. GCC Countries Market

            20.7.1.1. Introduction

            20.7.1.2. Market Analysis and Forecast by Market Taxonomy

                20.7.1.2.1. By Product

                20.7.1.2.2. By Test Type

                20.7.1.2.3. By Application

                20.7.1.2.4. By End User

        20.7.2. Türkiye Market

            20.7.2.1. Introduction

            20.7.2.2. Market Analysis and Forecast by Market Taxonomy

                20.7.2.2.1. By Product

                20.7.2.2.2. By Test Type

                20.7.2.2.3. By Application

                20.7.2.2.4. By End User

        20.7.3. South Africa Market

            20.7.3.1. Introduction

            20.7.3.2. Market Analysis and Forecast by Market Taxonomy

                20.7.3.2.1. By Product

                20.7.3.2.2. By Test Type

                20.7.3.2.3. By Application

                20.7.3.2.4. By End User

        20.7.4. North Africa Market

            20.7.4.1. Introduction

            20.7.4.2. Market Analysis and Forecast by Market Taxonomy

                20.7.4.2.1. By Product

                20.7.4.2.2. By Test Type

                20.7.4.2.3. By Application

                20.7.4.2.4. By End User

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies (Cholesterol and Lipid Tests)

    21.2. Market Share Analysis of Top Players

    21.3. Market Concentration

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Branding and Promotional Strategies, By Key Players

    22.3. Key Development Analysis

    22.4. Competition Deep Dive

        22.4.1. Boston Scientific Corporation

            22.4.1.1. Overview

            22.4.1.2. Product Portfolio

            22.4.1.3. Key Financials

            22.4.1.4. SWOT Analysis

            22.4.1.5. Key Developments

            22.4.1.6. Sales Footprint

            22.4.1.7. Strategy Overview

                22.4.1.7.1. Marketing Strategy

                22.4.1.7.2. Product Strategy

                22.4.1.7.3. Channel Strategy

        22.4.2. Medtronic

        22.4.3. Koninklijke Philips N.V.

        22.4.4. F. Hoffmann-La Roche Ltd.

        22.4.5. Abbott

        22.4.6. AstraZeneca

        22.4.7. LivaNova PLC

        22.4.8. BIOTRONIK SE & Co. KG

        22.4.9. ACON Laboratories, Inc.

        22.4.10. Spectra Laboratories, Inc.

        22.4.11. Eurofins Scientific,

        22.4.12. Randox Laboratories Ltd

        22.4.13. Quest Diagnostic

        22.4.14. Spectra Laboratories.

23. Assumptions and Acronyms Used

24. Research Methodology

Recommendations

Healthcare

Cholesterol Monitors Market

November 2017

REP-GB-5400

August 2023

342 pages

Healthcare

Cholesterol API Market

August 2022

REP-GB-15406

June 2023

342 pages

Healthcare

HDL Cholesterol Kits Market

February 2022

REP-GB-9842

July 2022

187 pages

Healthcare

Point-of-care Cholesterol Monitoring Device Market

December 2021

REP-GB-7773

June 2022

252 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Cholesterol and Lipid Test Market